|
1
|
Joki-Korpela P and Hyypiä T:
Parechoviruses, a novel group of human picornaviruses. Ann Med.
33:466–471. 2001.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mirand A, Archimbaud C, Chambon M,
Regagnon C, Brebion A, Bailly JL, Peigue-Lafeuille H and Henquell
C: Diagnosis of human parechovirus infections of the central
nervous system with a commercial real-time reverse
transcription-polymerase chain reaction kit and direct genotyping
of cerebrospinal fluid specimens. Diagn Microbiol Infect Dis.
74:78–80. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Centers for Disease Control and Prevention
(CDC). Nonpolio enterovirus and human parechovirus
surveillance-united states, 2006-2008. MMWR Morb Mortal Wkly Rep.
59:1577–1580. 2010.PubMed/NCBI
|
|
4
|
Nielsen ACY, Böttiger B, Midgley SE and
Nielsen LP: A novel enterovirus and parechovirus multiplex one-step
real-Time PCR-validation and clinical experience. J Virol Methods.
193:359–363. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Harvala H, McLeish N, K ondracka J,
McIntyre CL, Leitch ECM, Templeton K and Simmonds P: Comparison of
human parechovirus and enterovirus detection frequencies in
cerebrospinal fluid samples collected over a 5-year period in
edinburgh: HPeV type 3 identified as the most common picornavirus
type. J Méd Virol. 83:889–896. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
de Crom SC, Obihara CC, van Loon AM,
Argilagos-Alvarez AA, Peeters MF, van Furth AM and Rossen JW:
Detection of enterovirus RNA in cerebrospinal fluid: Comparison of
two molecular assays. J Virol Methods. 179:104–107. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Leber AL, Everhart K, Balada-Llasat JM,
Cullison J, Daly J, Holt S, Lephart P, Salimnia H, Schreckenberger
PC, DesJarlais S, et al: Multicenter evaluation of BioFire
FilmArray Meningitis/Encephalitis panel for detection of bacteria,
viruses, and yeast in cerebrospinal fluid specimens. J Clin
Microbiol. 54:2251–2261. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mizuta K, Yamakawa T, Nagasawa H, Itagaki
T, Katsushima F, Katsushima Y, Shimizu Y, Ito S, Aoki Y, Ikeda T,
et al: Epidemic myalgia associated with human parechovirus type 3
infection among adults occurs during an outbreak among children:
Findings from Yamagata, Japan, in 2011. J Clin Virol. 58:188–193.
2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mizuta K, Kuroda M, Kurimura M, Yahata Y,
Sekizuka T, Aoki Y, Ikeda T, Abiko C, Noda M, Kimura H, et al:
Epidemic myalgia in adults associated with human parechovirus type
3 Infection, Yamagata, Japan, 2008. Emerg Infect Dis. 18:1787–1793.
2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mizuta K, Yamakawa T, Kurokawa K, Chikaoka
S, Shimizy Y, Itagaki T, Katsushima F, Katsushima Y, Ito S, Aoki Y,
et al: Epidemic myalgia and myositis associated with human
parechovirus type 3 Infections occur not only in adults but also in
children: Findings in Yamagata, Japan, 2014. Epidemiol Infect.
144:1286–1290. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Westerhuis B, Kolehmainen P, Benschop K,
Nurminen N, Koen G, Koskiniemi M, Simell O, Knip M, Hyöty H,
Wolthers K and Tauriainen S: Human parechovirus seroprevalence in
finland and the netherlands. J Clin Virol. 58:211–215.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mardekian SK, Fortuna D, Nix A, Bhatti T,
Wiley CA, Flanders A, Urtecho J, Sloane J, Ahmad J and Curtis MT:
Severe human parechovirus type 3 myocarditis and encephalitis in an
adolescent with hypogammaglobulinemia. Int J Infect Dis. 36:6–8.
2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kong KL, Lau JSY, Goh SM, Wilson HL,
Catton M and Korman TM: Myocarditis caused by human parechovirus in
adult. Emerg Infect Dis. 23:1571–1573. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
de Groot-Mijnes JD, de Visser L, Zuurveen
S, Martinus RA, Völker R, ten Dam-van Loon NH, de Boer JH, Postma
G, de Groot RJ, van Loon AM and Rothova A: Identification of new
pathogens in the intraocular fluid of patients with uveitis. Am J
Ophthalmol. 150:628–636. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yamamoto SP, Kaida A, Naito T, Hosaka T,
Miyazato Y, Sumimoto S, Kohdera U, Ono A, Kubo H and Iritani N:
Human parechovirus infections and child myositis cases associated
with genotype 3 in Osaka City, Japan, 2014. J Méd Microbiol.
64:1415–1424. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
McGregor T, Bu'Lock FA, Wiselka M and Tang
JW: Human parechovirus infection as an undiagnosed cause of adult
pericarditis. J Infect. 75:596–597. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shinomoto M, Kawasaki T, Sugahara T,
Nakata K, Kotani T, Yoshitake H, Yuasa K, Saeki M and Fujiwara Y:
First report of human parechovirus type 3 infection in a pregnant
woman. Int J Infect Dis. 59:22–24. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nakamura K, Saito K, Hara Y, Aoyagi T,
Kitakawa K, Abe Y, Takemura H, Ikeda F, Kaku M and Kanemitsu K:
Severe epidemic myalgia with an elevated level of serum
Interleukin-6 caused by human parechovirus type 3: A case report
and brief review of the literature. BMC Infect Dis.
18(381)2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chimunda T, Subramanian R, Smith J and
Mahony A: First reported case of human parechovirus encephalitis in
an adult patient complicated by refractory status epilepticus.
IDCases. 15(e00475)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Miyazaki M, Hara K, Takayoshi T, Kawase T,
Nakagawa Y, Arai T, Sugimoto T, Nishiyama K, Gonzalez G, Hanaoka N,
et al: Epidemic myalgia associated with human parechovirus type 3
infection. Intern Med. 59:739–744. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Orimo K, Hatano K, Sato N, Okabe S, Suzuki
A, Mori K, Chiba T and Hashida H: Clinical characteristics of
epidemic myalgia associated with human parechovirus type 3 during
the summer of 2019. Intern Med. 59:1721–1726. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Masuda S, Koizumi K, Sato M, Uojima H,
Kimura K, Nishino T, Ichita C, Sasaki A, Makazu M, Kobayashi M, et
al: Severe generalized epidemic myalgia in an adult due to human
parechovirus type 3: A case report. Cureus.
14(e30587)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Abed Y and Boivin G: Human parechovirus
infections in Canada. Emerg Infect Dis. 12:969–975. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Watanabe K, Oie M, Higuchi M, Nishikawa M
and Fujii M: Isolation and characterization of novel human
parechovirus from clinical samples. Emerg Infect Dis. 13:889–895.
2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tanaka S, Kunishi Y, Ota M, Ono A, Kanno
N, Kurakami Y, Yanagibashi T, Matsubayashi M, Hao Y, Iwabuchi K, et
al: Severe human parechovirus type 3 infection in adults associated
with gastroenteritis in their children. Infect Dis (Lond).
49:772–774. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gagnier JJ, Kienle G, Altman DG, Moher D,
Sox H and Riley D: CARE Group. The CARE guidelines: Consensus-based
clinical case reporting guideline development. BMJ Case Rep.
2013(bcr2013201554)2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Piralla A, Furione M, Rovida F, Marchi A,
Stronati M, Gerna G and Baldanti F: Human parechovirus infections
in patients admitted to hospital in Northern Italy, 2008-2010. J
Méd Virol. 84:686–690. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Benschop KSM, Schinkel J, Minnaar RP,
Pajkrt D, Spanjerberg L, Kraakman HC, Berkhout B, Zaaijer HL, Beld
MG and Wolthers KC: Human parechovirus infections in dutch children
and the association between serotype and disease severity. Clin
Infect Dis. 42:204–210. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Sharp J, Harrison CJ, Puckett K, Selvaraju
SB, Penaranda S, Nix WA, Oberste MS and Selvarangan R:
Characteristics of young infants in whom human parechovirus,
enterovirus or neither were detected in cerebrospinal fluid during
sepsis evaluations. Pediatr Infect Dis J. 32:213–216.
2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kadambari S, Harvala H, Simmonds P,
Pollard AJ and Sadarangani M: Strategies to improve detection and
management of human parechovirus infection in young infants. Lancet
Infect Dis. 19:e51–e58. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Meyding-Lamadé U, Jacobi C,
Martinez-Torres F, Lenhard T, Kress B, Kieser M, Klose C, Einhäupl
K, Bösel J, Mackert MB, et al: The German trial on aciclovir and
corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): A
multicenter, randomized, double-blind, placebo-controlled trial.
Neurol Res Pract. 1(26)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Moscatt V, Marino A, Ceccarelli M,
Cosentino F, Zagami A, Celesia BM, Nunnari G and Cacopardo B:
Possible role of low dose dexamethasone administration in listeria
monocytogenes meningoencephalitis: A case series. Biomed Rep.
17(73)2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Beaman MH and Wesselingh SL: 4: Acute
Community-acquired meningitis and encephalitis. Méd J Aust.
176:389–396. 2002.PubMed/NCBI View Article : Google Scholar
|
